about
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensComputer aided selection of candidate vaccine antigens.Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions.A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithmsEmerging vaccine informatics.Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse VaccinologyPangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts.Integrative immunoinformatics for Mycobacterial diseases in R platform.Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.Immunoinformatics: an integrated scenario.The promise of reverse vaccinology.Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics.Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.Towards developing a vaccine for rheumatic heart disease.Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology.MalVac: database of malarial vaccine candidates.Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design.Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.
P2860
Q21328677-08A655C8-0EDC-46AA-A7B9-6F5966875661Q26777382-BDEC5D28-9A79-4A4E-BF00-58320FFB9A9EQ34312517-B3EE45F0-2520-42D9-8098-697D7D7FB1C9Q34787708-148D025B-8D48-44E6-80B7-462AC577FA5EQ35030321-F395A183-FF80-4078-83CA-C17595CBDE1CQ35100809-AD91B461-3957-4642-B69A-9A91B89774D8Q35549821-902C90BA-A34B-4DC2-A1CA-10BFDE237814Q36135237-B7D726F7-92A7-419E-8A38-F15635FC6D55Q36278990-8E9C837A-0986-476A-830D-BE360AE46670Q37214790-7094DFFE-5BC0-4136-B090-0979E0DE7C4FQ37601159-A7E17003-641B-4953-AB2A-E3335CDB8F55Q37691079-F2145755-2059-417A-A6A8-6251BFAF9E21Q37781086-32BF8737-31D6-4123-BABA-75E34C45B65EQ38367088-5CB6E87C-E049-4608-8A61-C8A0B966689FQ38789472-E512D8FA-136E-45EB-AD6B-848D499CA7FAQ38910649-D0B8E419-B97E-443C-8193-C816C7545414Q41928281-08447784-8090-40EB-89F2-A3F8D42C3402Q42024639-AF8CEA8D-6765-440B-A27C-99F65EF94C59Q42098879-9959B968-3578-43E8-9A43-F3D2747ACABEQ44119319-EEB65FBC-E122-4C8D-A4A7-AE731F43BD06Q51416013-AF05B04E-D911-45AB-BA3F-903E82E24452
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NERVE: new enhanced reverse vaccinology environment
@ast
NERVE: new enhanced reverse vaccinology environment
@en
type
label
NERVE: new enhanced reverse vaccinology environment
@ast
NERVE: new enhanced reverse vaccinology environment
@en
prefLabel
NERVE: new enhanced reverse vaccinology environment
@ast
NERVE: new enhanced reverse vaccinology environment
@en
P2093
P2860
P356
P1433
P1476
NERVE: new enhanced reverse vaccinology environment
@en
P2093
Filippo Bernante
Francesco Filippini
Sandro Vivona
P2860
P2888
P356
10.1186/1472-6750-6-35
P577
2006-07-18T00:00:00Z
P5875
P6179
1001603213